including Chol and fusogenic lipids, and a PEG lipid (Table 2). In SNALPs, the backbone-modified siRNA is encapsulated within a closed shell of a cationic-zwitterionic lipid bilayer, furnished ...
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
Stable nucleic acid lipid particle formulations in systemic delivery Target siRNA and modification (yes/no) Animal model Ref. DSPC:Chol:PEG–C–DMA:DLin–DMA (20:48:2:30)–siRNA Hepatitis B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback